Generalized Lymphadenopathy due to Chronic Lymphocytic Leukemia (CLL) : 18F-FDG PET Imaging
Author(s) -
Basuki Hidayat,
Febby Hutomo,
Ryan Yudistiro,
Ivana Dewi Mulyanto,
Hendra Budiawan,
Johan S. Masjhur
Publication year - 2016
Publication title -
journal of medicine and health
Language(s) - English
Resource type - Journals
ISSN - 2442-5257
DOI - 10.28932/jmh.v1i3.520
Subject(s) - chronic lymphocytic leukemia , medicine , positron emission tomography , lymphoma , leukemia , differential diagnosis , pet ct , pathology , radiology , nuclear medicine
Lymphadenopaty is a common clinical finding with a broad differential diagnosis, withCarcinoma of Unknown Primary (CUP) as one of it’s most common causes. Flourine-18 fluoro-2 deoxy glucose (18F- FDG) positron emission tomography (PET) is a Nuclear Medicinescintigraphy procedure commonly used to localize suspected a primary lesion by depicting ametabolic status. However, in the expertise of 18F FDG PET study, clinical finding andepidemiologic data must be considered to get a better conclusion. We describe 18F-FDG PETstudy in the presence of generalized lymphadenopathy due to chronic lymphocytic leukemia(CLL), a rare disease which is initially suspected of having CUP.Keywords: 18F-FDG PET, lymphadenopathy, lymphoma, leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom